Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ARWR
Arrowhead Research Soars After Acquiring Novartis' RNAi Portfolio
Morning Market Gainers
Related FMI
The Best Biotech ETF Isn't Always The Biggest
Wedbush Previews Foundation Medicine, Expects In-Line Earnings

Analysts at Piper Jaffray initiated coverage on shares of Arrowhead Research (NASDAQ: ARWR) with an “overweight” rating. The target price for Arrowhead Research is set to $12. Arrowhead Research's shares closed at $7.87 on Friday.

Analysts at Goldman Sachs initiated coverage on shares of Foundation Medicine (NASDAQ: FMI) with a “neutral” rating. The target price for Foundation Medicine is set to $33. Foundation Medicine's stock closed at $33.99 on Friday.

JP Morgan initiated coverage on shares of Premier (NASDAQ: PINC) with an “overweight” rating. The target price for Premier is set to $36. Premier's shares closed at $31.66 on Friday.

Morgan Stanley initiated coverage on shares of Ophthotech (NASDAQ: OPHT) with an “overweight” rating. The target price for Ophthotech is set to $56. Ophthotech's shares closed at $29.25 on Friday.

Latest Ratings for ARWR

DateFirmActionFromTo
Jan 2015Deutsche BankDowngradesBuyHold
Oct 2014RBC CapitalDowngradesOutperformSector Perform
Oct 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for ARWR
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ARWR + FMI)

Around the Web, We're Loving...